2 high-yielding stocks I’d buy before Pearson plc

Avoiding Pearson plc (LON: PSON) after its annus horribilis? Here are two alternative high yields.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Education publisher Pearson (LSE: PSON) reported the largest pre-tax loss in its history on Friday. A change of strategy in the last few years, including the disposal of The Financial Times and French media group Les Echos, combined with a slowdown in key market North America has led to a slew of profit warnings and the £2.56bn 2016 pre-tax loss.

The shares have fallen 20% in the last month, but is the company now a buy?

The loss is attributable largely to a massive £2.55bn impairment of goodwill reflecting poor trading in the North American business. Adjusted operating profit fell 27% at constant exchange rates, but the weaker pound resulted in a more flattering 12% drop after an 8% fall in underlying sales.

The company is also planning on selling its 48% stake in publisher Penguin Random House and plans to use the proceeds to pay down debt and invest in digital, which now accounts for 68% of revenues.

The company has completed its restructuring programme, spending £338m to reduce its cost base by £425m. 2017 operating profit is predicted to come in at £570m-£630m. If we trust these forecasts, the company trades below 10 times operating profit. 2016’s dividend payments total 52p per share, but the company has clearly stated its intention to rebase (read: cut) the dividend next year.

Even if the payout is halved, the shares still yield 3.83%. That said, I believe there is simply too much uncertainty in Pearson’s key markets to invest. Here are two other high-yielding businesses I’d consider instead of Pearson.

Merger to create global dividend titan

British American Tobacco (LSE: BATS) had a far more successful 2016 than Pearson, with revenues rising 12.6%, or 7% if favourable currency rates are ignored. Operating profit came in at £4,655m, for an impressive margin of 31.6%.

This performance was largely driven by an average 50bps market share gain in the company’s major markets. The Global Drive Brand portfolio, which consists of Dunhill, Kent, Lucky Strike and Pall Mall, outperformed the rest of the company with volume up 7.5% and a market share gain of 100bps.

Perhaps the most significant recent news is that the firm has agreed terms to acquire the remaining 57.8% of Reynolds American for $50bn. This will create the largest listed tobacco company in the world as well as marking a full-scale return to the American market for BATS, as well as providing increased efficiencies and economies of scale.

The combination of these two defensive cash-cows could facilitate chunky dividends for years to come. Even if the deal doesn’t go ahead, BATS would be set to yield 3.4%.

Another defensive yield?

BAE Systems (LSE: BA.) also had a successful 2016, with sales jumping 6.2%, although this was largely due to favourable exchange rates. Operating profit fared better, increasing to £1,742m, or a 10% gain on a constant currency basis.

Order intake increased by £7.5bn to £22.4bn, while the order backlog increased by £5.2bn to £42bn after contract wins in the UK and the US. The company paid a 21.3p per share dividend last year, representing a 3.5% yield. 

The short-term outlook for BAE seems strong. US defence spending will likely increase under Trump, which should bode well for the company, although it would be remiss of me to avoid mentioning the massive £6.1bn pension deficit, which could cause problems in the long term.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Zach Coffell has no position in any shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

After it crashed 25%, should I buy this former stock market darling in my Stocks and Shares ISA?

Harvey Jones has a big hole in his Stocks and Shares ISA that he is keen to fill. Should he…

Read more »

happy senior couple using a laptop in their living room to look at their financial budgets
Investing Articles

How’s the dividend forecast looking for Legal & General shares in 2025 and beyond?

As a shareholder, I like to keep track of the potential dividend returns I could make from my Legal &…

Read more »

artificial intelligence investing algorithms
Investing Articles

Could buying this stock with a $7bn market cap be like investing in Nvidia in 2010?

Where might the next Nvidia-type stock be lurking in today's market? Our writer takes a look at one candidate with…

Read more »

Investing Articles

Is GSK a bargain now the share price is near 1,333p?

Biopharma company GSK looks like a decent stock to consider for the long term, so is today's lower share price…

Read more »

Snowing on Jubilee Gardens in London at dusk
Investing Articles

Could December be a great month to buy UK shares?

Christopher Ruane sees some possible reasons to look for shares to buy in December -- but he'll be using the…

Read more »

Young mixed-race couple sat on the beach looking out over the sea
Investing Articles

Sticking to FTSE shares, I’d still aim for a £1,000 monthly passive income like this!

By investing in blue-chip FTSE shares with proven business models, our writer hopes he can build sizeable passive income streams…

Read more »

Growth Shares

BT shares? I think there are much better UK stocks for the long term

Over the long term, many UK stocks have performed much better than BT. Here’s a look at two companies that…

Read more »

British Pennies on a Pound Note
Investing Articles

After a 540% rise, could this penny share keep going?

This penny share has seen mixed fortunes in recent years. Our writer looks ahead to some potentially exciting developments in…

Read more »